Timothy Price/LinkedIn
May 9, 2025, 15:23
Timothy Price Shares SACCaN Launch and Leadership Transition Update
Timothy Price, Interim Clinical Trials Chair at SACCaN, shared a post on LinkedIn:
“SACCaN was formally announced and launched 2 weeks ago now by Minister Butler and Minister Picton.
It has been a privilege being the Clinical Director working with amazing colleagues during the set-up phase which led to the formal announcement. I particularly want to thank THRF who have supported the team to this point. Having obtained the $87 million dollars in grants we now need to move to the next phase of establishing SACCaN and with this we see the established Cancer Statewide Clinical network and SACCAN evolve into one Cancer Network for South Australia.
With this A/Prof Michael Osborne as current Network Chair will be the ongoing Interim Clinical Director of SACCaN from today awaiting the formal process of appointing a permanent Director. Michael through his leadership and experience of leading the SA Cancer Network is well placed to lead this next important chapter.
I will now focus on the Clinical Trials program within SACCaN as the Interim Clinical Trials Chair while we await a formal EOI for this role.”
More posts on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 9, 2025, 15:23
May 9, 2025, 15:02
May 9, 2025, 14:59